Lan Dai

907 total citations
39 papers, 701 citations indexed

About

Lan Dai is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Lan Dai has authored 39 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Cell Biology. Recurrent topics in Lan Dai's work include Sphingolipid Metabolism and Signaling (10 papers), Retinoids in leukemia and cellular processes (6 papers) and Caveolin-1 and cellular processes (5 papers). Lan Dai is often cited by papers focused on Sphingolipid Metabolism and Signaling (10 papers), Retinoids in leukemia and cellular processes (6 papers) and Caveolin-1 and cellular processes (5 papers). Lan Dai collaborates with scholars based in China, Australia and Fiji. Lan Dai's co-authors include Wen Di, Lihua Qiu, Liankun Gu, Keqi Song, Pu Xia, Xingchen Zhou, Yanfei Qi, Liying Gu, Yunfei Wang and Wenwen Wang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Lan Dai

37 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Dai China 16 404 233 150 112 95 39 701
R E Leake United Kingdom 17 321 0.8× 206 0.9× 67 0.4× 103 0.9× 40 0.4× 34 796
Han‐Hsuan Fu United States 9 406 1.0× 237 1.0× 148 1.0× 122 1.1× 54 0.6× 10 758
Shengsheng Yang China 17 396 1.0× 312 1.3× 61 0.4× 52 0.5× 37 0.4× 34 734
Rezina Arju United States 11 617 1.5× 168 0.7× 136 0.9× 86 0.8× 65 0.7× 16 933
Lilach Kleinberg Norway 19 521 1.3× 252 1.1× 179 1.2× 139 1.2× 125 1.3× 27 1.1k
Mary Peavey United States 10 231 0.6× 86 0.4× 579 3.9× 126 1.1× 41 0.4× 26 936
Sufang Wu China 18 484 1.2× 325 1.4× 116 0.8× 25 0.2× 25 0.3× 39 725
Huey‐Jen Lin United States 14 707 1.8× 248 1.1× 123 0.8× 33 0.3× 57 0.6× 22 1.1k
Manon de Ladurantaye Canada 13 265 0.7× 129 0.6× 77 0.5× 68 0.6× 40 0.4× 17 574
Ruo-Pan Huang United States 7 341 0.8× 115 0.5× 89 0.6× 32 0.3× 26 0.3× 9 573

Countries citing papers authored by Lan Dai

Since Specialization
Citations

This map shows the geographic impact of Lan Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Dai more than expected).

Fields of papers citing papers by Lan Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Dai. The network helps show where Lan Dai may publish in the future.

Co-authorship network of co-authors of Lan Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Dai. A scholar is included among the top collaborators of Lan Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Dai. Lan Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Lan, et al.. (2025). T cell subsets in cervical cancer tumor microenvironment: advances and therapeutic opportunities. Frontiers in Immunology. 16. 1612032–1612032. 1 indexed citations
2.
3.
Dai, Lan, Jianfeng Huang, Lei Hu, et al.. (2023). Efficacy of Nimotuzumab plus Concurrent Chemo-Radiotherapy for Unresectable Esophageal Cancer: A Real-World Study. International Journal of Radiation Oncology*Biology*Physics. 117(2). e354–e354. 1 indexed citations
4.
Dai, Lan, et al.. (2021). Carbamazepine Induces Platelet Apoptosis and Thrombocytopenia Through Protein Kinase A. Frontiers in Pharmacology. 12. 749930–749930. 11 indexed citations
5.
Dai, Lan, Chen Wang, Keqi Song, Wenjing Wang, & Wen Di. (2021). Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation. Journal of Ovarian Research. 14(1). 62–62. 10 indexed citations
6.
Dai, Lan, Wenjing Wang, Yixuan Liu, Keqi Song, & Wen Di. (2021). Inhibition of sphingosine kinase 2 down-regulates ERK/c-Myc pathway and reduces cell proliferation in human epithelial ovarian cancer. Annals of Translational Medicine. 9(8). 645–645. 8 indexed citations
7.
Song, Keqi, Lan Dai, Xiaoran Long, Wenjing Wang, & Wen Di. (2020). Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase. Scientific Reports. 10(1). 13834–13834. 31 indexed citations
8.
Dai, Lan, Keqi Song, & Wen Di. (2020). Adipocytes: active facilitators in epithelial ovarian cancer progression?. Journal of Ovarian Research. 13(1). 115–115. 35 indexed citations
9.
Song, Keqi, et al.. (2019). <p>Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo</p>. OncoTargets and Therapy. Volume 12. 4437–4449. 15 indexed citations
10.
Dai, Lan, Yixuan Liu, Lei Xie, et al.. (2017). Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis. Oncotarget. 8(43). 74947–74961. 40 indexed citations
11.
Dai, Lan, Ri Zhang, Zhaoyue Wang, et al.. (2016). Efficacy of immunomodulatory therapy with all- trans retinoid acid in adult patients with chronic immune thrombocytopenia. Thrombosis Research. 140. 73–80. 19 indexed citations
12.
Qi, Yanfei, Wei Wang, Jinbiao Chen, et al.. (2015). Sphingosine Kinase 1 Protects Hepatocytes from Lipotoxicity via Down-regulation of IRE1α Protein Expression. Journal of Biological Chemistry. 290(38). 23282–23290. 27 indexed citations
13.
14.
Dai, Lan, Pu Xia, & Wen Di. (2014). Sphingosine 1-phosphate: A Potential Molecular Target for Ovarian Cancer Therapy?. Cancer Investigation. 32(3). 71–80. 28 indexed citations
15.
Zhang, Ning, Lan Dai, Yanfei Qi, Wen Di, & Pu Xia. (2013). Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: Role of autophagy. International Journal of Oncology. 42(6). 2053–2059. 26 indexed citations
16.
17.
Dai, Lan, Liankun Gu, & Wen Di. (2011). MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKK /NF- B pathway and reduced interleukin-8 expression. Molecular Human Reproduction. 18(3). 136–145. 88 indexed citations
18.
Dai, Lan & Wen Di. (2011). [Role of microRNA in the occurrence and development of endometriosis].. PubMed. 46(4). 304–6. 3 indexed citations
19.
Dai, Lan, et al.. (2009). TWEAK promotes ovarian cancer cell metastasis via NF-κB pathway activation and VEGF expression. Cancer Letters. 283(2). 159–167. 46 indexed citations
20.
Wang, Zhaoyue, et al.. (2006). [The fibrinolytic activity in leukemic cell lines and its alteration on all-trans retinoic acid treatment].. PubMed. 27(9). 588–92. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R E Leake Breakdown of academic impact, for papers by Han‐Hsuan Fu Breakdown of academic impact, for papers by Shengsheng Yang Breakdown of academic impact, for papers by Rezina Arju Breakdown of academic impact, for papers by Lilach Kleinberg Breakdown of academic impact, for papers by Mary Peavey Breakdown of academic impact, for papers by Sufang Wu Breakdown of academic impact, for papers by Huey‐Jen Lin Breakdown of academic impact, for papers by Manon de Ladurantaye Breakdown of academic impact, for papers by Ruo-Pan Huang
Rankless by CCL
2026